These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10581761)

  • 41. [Autoimmune hepatitis and overlap syndrome: therapy].
    Löhr HF
    Praxis (Bern 1994); 2002 Aug; 91(34):1347-51. PubMed ID: 12233265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter.
    Omori K; Yoshida K; Yokota M; Daa T; Kan M
    Clin J Gastroenterol; 2016 Oct; 9(5):312-8. PubMed ID: 27503128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.
    Efe C; Ozaslan E; Nasiroglu N; Tunca H; Purnak T; Altiparmak E
    Dig Dis Sci; 2010 Aug; 55(8):2417-21. PubMed ID: 19826950
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 47. [Diagnosis and therapy: autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis].
    Strassburg CP
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S202-4. PubMed ID: 16435709
    [No Abstract]   [Full Text] [Related]  

  • 48. Development of autoimmune hepatitis in primary biliary cirrhosis.
    Gossard AA; Lindor KD
    Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of cholestatic liver diseases].
    Gatzen M; Pausch J
    Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pathologic diagnosis of autoimmune liver disease].
    Pan MH; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):772-6. PubMed ID: 18307886
    [No Abstract]   [Full Text] [Related]  

  • 55. Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis.
    To U; Silveira M
    Clin Liver Dis; 2018 Aug; 22(3):603-611. PubMed ID: 30259856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.
    Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S3-12. PubMed ID: 23141891
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overlap syndromes of autoimmune hepatitis: an open question.
    Durazzo M; Premoli A; Paschetta E; Belci P; Spandre M; Bo S
    Dig Dis Sci; 2013 Feb; 58(2):344-8. PubMed ID: 23086110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Vallone TM; Ditelberg J; Kaplan MM
    Dig Dis Sci; 2005 Jan; 50(1):167-70. PubMed ID: 15712656
    [No Abstract]   [Full Text] [Related]  

  • 60. [Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis].
    MMW Fortschr Med; 2008 Apr; 150(15):45. PubMed ID: 18510120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.